Article Sidebar
Published:
Jan 18, 2022DOI:
10.4314/tjpr.v20i4.1Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Preparation, characterization and stability of silver sulfadiazine nanoliposomes
Abstract
Purpose: To prepare, characterize and investigate the stability and drug release profile of silver sulfadiazine (AgSD) nanoliposomes as functions of pH, UV exposure, and/or heat.
Methods: Silver sulfadiazine (AgSD) nanoliposomes were prepared. The stability and release properties of the free drug and nanoliposomal formulations of AgSD as functions of pH, UV exposure, and/or heat were analyzed. The analyses were performed at different time points.
Results: The results of characterization showed that acidic, basic and neutral silver sulfadiazine nano-liposomal suspensions (AgSD NLSs) were produced as stable homogenous formulations, as indicated by low polydispersity index (PDI) and high zeta potential. The three AgSD NLSs and AgSD were unstable under different heat and/or UV conditions. The pH tended to shift towards neutrality, starting from day 1. Silver sulfadiazine nanoliposomal suspensions (AgSD NLSs) and free drug (AgSD) exhibited similar release properties (100 % of the drug was released at day 12).
Conclusion: Incorporation of AgSD into nanoliposomes has no significant effect on the stability and in vitro release properties of the drug. This indicates that NLS did not change the physical characteristics of the drug. Studies that focus only on improving the lipophilicity of silver sulfadiazine may benefit from these results.
